Drug recall · February 22, 2023
TPN (a) 115GM/AA recall
Why: Lack of sterility assurance
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TPN (a) 115GM/AA, 215GM/DEX, 25GM/LIP 1150ML, (b)90GM/AA, 215GM/DEX, 25GM/LIP 1150ML, (c) TPN AA: 100GM DEX: 105GM 2700ML, (d) TPN AA: 100GM DEX: 105GM LIP: 45GM 2700ML, (e) TPN: AA100GM ; DEX185GM ; LIP50GM IN 1500ML, (f) TPN: AA 150GM ; DEX 220GM ; LIP 45GM IN 2400 ml, (g) TPN: AA 60GM ; DEX 200GM ; LIP 30GM IN 1500 ml, Rx only, use with Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
- Lots / codes
Beyond Use Date: December 24-31, 2022
- Quantity
- 31 bags
- Company
- Sentara Infusion Services, Chesapeake, VA
- Distribution
- Dispensed to Patients Nationwide.
- Initiated
- December 27, 2022 · Voluntary: Firm initiated
- Classified
- February 15, 2023
- Reported
- February 22, 2023
- Ended
- February 20, 2026
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.